Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

8.6K
8.6K
Ligand Binding Sites02:40

Ligand Binding Sites

14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.0K
4.0K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K
Conserved Binding Sites01:49

Conserved Binding Sites

5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K
Conserved Binding Sites01:49

Conserved Binding Sites

1.9K
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of Serum IgG1 to Predict Progression and Therapeutic Effect in Patients with Multiple Myeloma.

Journal of oncology·2022
Same author

Long-term maternal intake of inulin exacerbated the intestinal damage and inflammation of offspring rats in a DSS-induced colitis model.

Food & function·2022
Same author

Direct imaging of the disconnection climb mediated point defects absorption by a grain boundary.

Nature communications·2022
Same author

Glomus tumors around or in the knee: a case report and literature review.

BMC surgery·2022
Same author

Protein FT-IR amide bands are beneficial to bacterial typing.

International journal of biological macromolecules·2022
Same author

Restorative Effects of Inulin From <i>Codonopsis pilosula</i> on Intestinal Mucosal Immunity, Anti-Inflammatory Activity and Gut Microbiota of Immunosuppressed Mice.

Frontiers in pharmacology·2022

Related Experiment Video

Updated: Jan 14, 2026

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

2.0K

Hierarchical affinity landscape navigation through learning a shared pocket-ligand space.

Bin Feng1, Zijing Liu1, Hao Li1

  • 1International Digital Economy Academy (IDEA), Shenzhen, China.

Patterns (New York, N.Y.)
|October 27, 2025
PubMed
Summary
This summary is machine-generated.

LigUnity, a novel foundation model, unifies ligand and protein pocket structures for accurate drug affinity prediction. This integrated approach enhances both virtual screening and hit-to-lead optimization in drug discovery.

Keywords:
affinity predictionhit-to-lead optimizationpharmacophore rankingscaffold discriminationshared spacevirtual screening

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K

Related Experiment Videos

Last Updated: Jan 14, 2026

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

2.0K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K

Area of Science:

  • Computational chemistry and cheminformatics
  • Drug discovery and development
  • Structural biology and molecular modeling

Background:

  • Protein binding pocket structure dictates ligand binding affinity through interactions and spatial fit.
  • Current drug discovery methods often separate virtual screening and hit-to-lead optimization due to speed-accuracy trade-offs.
  • Integrating these tasks allows for broader chemical exploration and focused optimization on key substructures.

Purpose of the Study:

  • To introduce LigUnity, a foundation model for unified affinity prediction by embedding ligands and pockets in a shared space.
  • To enable simultaneous coarse-grained (scaffold discrimination) and fine-grained (pharmacophore ranking) affinity prediction.
  • To demonstrate LigUnity's effectiveness and versatility across diverse drug discovery benchmarks.

Main Methods:

  • Development of LigUnity, a foundation model integrating ligand and protein pocket representations.
  • Utilizing scaffold discrimination for active/inactive classification and pharmacophore ranking for pocket-specific ligand preference.
  • Validation across eight benchmarks in six settings, including virtual screening and hit-to-lead optimization scenarios.

Main Results:

  • LigUnity significantly outperforms 24 existing methods in virtual screening (>50% improvement) with robust generalization to new targets.
  • Achieves state-of-the-art performance in hit-to-lead optimization across various data splitting strategies.
  • Demonstrates cost-efficiency compared to free energy perturbation methods and successful application in an active learning framework for TYK2 ligand discovery.

Conclusions:

  • LigUnity establishes itself as a versatile foundation model for affinity prediction.
  • Offers broad applicability across the entire drug discovery pipeline, from screening to optimization.
  • Represents a significant advancement in computational drug design, improving efficiency and accuracy.